487 related articles for article (PubMed ID: 1646716)
1. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
[TBL] [Abstract][Full Text] [Related]
2. Domain structure of the endothelial cell receptor thrombomodulin as deduced from modulation of its anticoagulant functions. Evidence for a glycosaminoglycan-dependent secondary binding site for thrombin.
Preissner KT; Koyama T; Müller D; Tschopp J; Müller-Berghaus G
J Biol Chem; 1990 Mar; 265(9):4915-22. PubMed ID: 2156859
[TBL] [Abstract][Full Text] [Related]
3. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
Scully MF; Ellis V; Seno N; Kakkar VV
Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
[TBL] [Abstract][Full Text] [Related]
4. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
[TBL] [Abstract][Full Text] [Related]
5. Role of the glycosaminoglycan component of thrombomodulin in its acceleration of the inactivation of single-chain urokinase-type plasminogen activator by thrombin.
de Munk GA; Parkinson JF; Groeneveld E; Bang NU; Rijken DC
Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):655-9. PubMed ID: 8384442
[TBL] [Abstract][Full Text] [Related]
6. The effect of human thrombomodulin on the inactivation of thrombin by human antithrombin III.
Hirahara K; Koyama M; Matsuishi T; Kurata M
Thromb Res; 1990 Jan; 57(1):117-26. PubMed ID: 2154059
[TBL] [Abstract][Full Text] [Related]
7. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity.
Sheehan JP; Wu Q; Tollefsen DM; Sadler JE
J Biol Chem; 1993 Feb; 268(5):3639-45. PubMed ID: 8429040
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
9. Effect of rabbit thrombomodulin on thrombin inhibition by antithrombin in the presence of heparin.
Bourin MC
Thromb Res; 1989 Apr; 54(1):27-39. PubMed ID: 2543098
[TBL] [Abstract][Full Text] [Related]
10. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
[TBL] [Abstract][Full Text] [Related]
11. Binding of thrombin to thrombomodulin accelerates inhibition of the enzyme by antithrombin III. Evidence for a heparin-independent mechanism.
Preissner KT; Delvos U; Müller-Berghaus G
Biochemistry; 1987 May; 26(9):2521-8. PubMed ID: 3038185
[TBL] [Abstract][Full Text] [Related]
12. The effects of human thrombomodulin on the inactivation of thrombin by its serum inhibitors.
Thompson EA; Salem HH
Thromb Haemost; 1987 Oct; 58(3):806-10. PubMed ID: 2829375
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
[TBL] [Abstract][Full Text] [Related]
15. Heparin cofactor II inhibits thrombin-stimulated release of tissue plasminogen activator from cultured human endothelial cells in the presence of dermatan sulfate.
Kaji T; Ejiri N; Hayakawa Y; Hayashi T; Sakuragawa N
Thromb Res; 1990 Jul; 59(2):269-77. PubMed ID: 2122537
[TBL] [Abstract][Full Text] [Related]
16. Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma.
Simmons RB; Newton GR; Doctor VM
Eur J Drug Metab Pharmacokinet; 1995; 20(1):73-7. PubMed ID: 7588997
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of thrombin inhibition by heparin cofactor II in the presence of dermatan sulphates, native or oversulphated, and a heparin-like dextran derivative.
Maaroufi RM; Jozefowicz M; Tapon-Bretaudière J; Jozefonvicz J; Fischer AM
Biomaterials; 1997 Feb; 18(4):359-66. PubMed ID: 9068899
[TBL] [Abstract][Full Text] [Related]
18. [The antithrombin action of stichopus japonicus acid mucopolysaccharide (Sjamp) is mediated by heparin cofactor II].
Zhang G
Zhonghua Xue Ye Xue Za Zhi; 1997 Mar; 18(3):126-9. PubMed ID: 15622771
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of potentiation of antithrombin III and heparin cofactor II inhibition by sulfated xylans.
Carson L; Doctor VM
Thromb Res; 1990 May; 58(4):367-81. PubMed ID: 1972302
[TBL] [Abstract][Full Text] [Related]
20. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.
Liaw PC; Austin RC; Fredenburgh JC; Stafford AR; Weitz JI
J Biol Chem; 1999 Sep; 274(39):27597-604. PubMed ID: 10488098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
